4-hydroxycyclophosphamide has been researched along with Leukemia L 1210 in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (50.00) | 18.7374 |
| 1990's | 1 (25.00) | 18.2507 |
| 2000's | 1 (25.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Higashigawa, M; Kagawa, Y; Komada, Y; Noge, I | 1 |
| Hilton, J | 1 |
| Baturay, N; Kwon, CH; Moon, KY; Shirota, FN | 1 |
| Borch, RF; Kwon, CH | 1 |
4 other study(ies) available for 4-hydroxycyclophosphamide and Leukemia L 1210
| Article | Year |
|---|---|
Combined antitumor effect of cyclophosphamide and bromodeoxyuridine in BDF1 mice bearing L1210 ascites tumors.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Bromodeoxyuridine; Cyclophosphamide; Dose-Response Relationship, Drug; Leukemia L1210; Male; Mice | 2008 |
Role of aldehyde dehydrogenase in cyclophosphamide-resistant L1210 leukemia.
Topics: Aldehyde Dehydrogenase; Animals; Cell Survival; Cyclophosphamide; DNA, Neoplasm; Drug Resistance; Leukemia L1210; Mice; Mice, Inbred Strains | 1984 |
Chemically stable N-methyl-4-(alkylthio)cyclophosphamide derivatives as prodrugs of 4-hydroxycyclophosphamide.
Topics: 3T3 Cells; Animals; Antineoplastic Agents; Biotransformation; Cell Survival; Cyclophosphamide; Drug Screening Assays, Antitumor; Drug Stability; Humans; Leukemia L1210; Male; Mice; Mice, Inbred BALB C; Microsomes, Liver; Prodrugs; Rats; Rats, Sprague-Dawley; Tumor Cells, Cultured | 1995 |
Effects of N-substitution on the activation mechanisms of 4-hydroxycyclophosphamide analogues.
Topics: Animals; Antineoplastic Agents; Biotransformation; Cell Survival; Chemical Phenomena; Chemistry; Cyclophosphamide; Half-Life; Humans; Leukemia L1210; Mice; Nitrogen; Tumor Cells, Cultured | 1989 |